Tech Center 1600 • Art Units: 1671 1672
This examiner grants 27% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17835751 | SELF-ASSEMBLING VIRAL SPIKE-EABR NANOPARTICLES | Final Rejection | California Institute of Technology |
| 17925920 | CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 17490419 | SARS-CoV2 Antigen Lateral Flow Assay Detection Device and Methods of Using the Same | Final Rejection | Becton, Dickinson and Company |
| 17632733 | TRANSPLANT DIAGNOSTICS USING CRISPR-BASED TECHNOLOGY | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17457594 | METHOD FOR DETECTION OF VIRAL INFECTIONS USING SPLIT ENZYMES | Non-Final OA | Brigham Young University |
| 18146873 | ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF | Non-Final OA | ACADEMIA SINICA |
| 17696646 | METHOD FOR RAPID PREPARATION OF EPIDEMIC INFECTIOUS BRONCHITIS VACCINE | Final Rejection | SOUTH CHINA AGRICULTURAL UNIVERSITY |
| 17905614 | VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSES | Non-Final OA | The Government of the United States, as Represented by the Secretary of the Army |
| 17504644 | METHOD AND PLATFORM FOR ENHANCING DETECTION ACTIVITY OF INTERACTION BETWEEN SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF CORONAVIRUS FROM SPECIMEN AND HUMAN ANGIOTENSIN-CONVERTING ENZYME II | Non-Final OA | National Tsing Hua University |
| 18769686 | METHODS OF PRODUCING RECOMBINANT ADENOVIRUS VECTORS | Final Rejection | Ferring International Center S.A. |
| 17906310 | PADLOCK PROBE-BASED ROLLING CIRCLE AMPLIFICATION PAIRED WITH NUCLEASE PROTECTION FOR POINT-OF-NEED NUCLEIC ACID DETECTION | Final Rejection | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION |
| 18015918 | A SIMPLE METHOD FOR COLLECTING A SAMPLE OF A MUCOSAL FLUID ADHERED TO THE MUCOSAL SURFACE OF THE NASAL CAVITY AND A TEST KIT FOR DETECTING AN ANALYTE IN THE SAMPLE | Non-Final OA | Denka Company Limited |
| 17919096 | ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT | Final Rejection | DENKA COMPANY LIMITED |
| 18004964 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ROTAVIRUS | Non-Final OA | The Wistar Institute of Anatomy and Biology |
| 17493103 | FUSION PROTEIN COMPRISING CIRCOVIRIDAE CAPSID PROTEIN, AND CHIMERIC VIRUS-LIKE PARTICLES COMPOSED THEREOF | Non-Final OA | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. |
| 18008826 | POLYPEPTIDE VACCINE COUPLED WITH TLR7 AGONIST FOR NOVEL CORONAVIRUS AND USE THEREOF | Non-Final OA | SHENZHEN UNIVERSITY |
| 16976277 | EXOSOME TARGETING OF CD4+ EXPRESSING CELLS | Final Rejection | Rhode Island Hospital |
| 18016930 | BROADLY NEUTRALIZING BINDING MOLECULES AGAINST MARBURGVIRUSES | Non-Final OA | La Jolla Institute for Immunology |
| 17997266 | METHODS AND KITS FOR DETECTING ADENO-ASSOCIATED VIRUSES | Final Rejection | LONZA HOUSTON, INC. |
| 18011789 | METHOD FOR MASS-PRODUCING VACCINIA VIRUS BY USING SUSPENSION CELLS | Final Rejection | KOLON LIFE SCIENCE, INC. |
| 18042083 | REAGENTS AND METHODS FOR PREVENTING, TREATING OR LIMITING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) CORONAVIRUS INFECTION | Non-Final OA | PHYLEX BIOSCIENCES, INC. |
| 18020210 | COMPOSITIONS FOR TREATING GASTROINTESTINAL ADENOCARCINOMAS BY ALTERING THE TUMOR MICROENVIRONMENT | Final Rejection | Nordic Science Group ApS |
| 18005429 | ANTIGENS, ASSAYS, AND METHODS ASSOCIATED WITH SARS-COV-2 | Non-Final OA | KREUTZ, Fernando Thome |
| 18004148 | A DNA PLASMID SARS-CORONA VIRUS-2/COVID-19 VACCINE | Non-Final OA | STATENS SERUM INSTITUT |
| 17925766 | VIRUS STABILIZER, GELATIN HYDROLYSATE FOR VIRUS STABILIZER, AND VIRUS-CONTAINING COMPOSITION | Final Rejection | INCORPORATED EDUCATIONAL INSTITUTION RAKUNO GAKUEN |
| 17803699 | REPLICATION-COMPETENT CONTROLLED HERPESVIRUSES EXPRESSING A SARS COV-2 ANTIGEN | Final Rejection | HSF Pharmaceuticals SA |
| 17908221 | CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST | Non-Final OA | Dynavax Technologies Corporation |
| 17606614 | DOSAGE REGIMENS FOR AND COMPOSITIONS INCLUDING ANTI-RSV ANTIBODIES | Final Rejection | SANOFI PASTEUR INC. |
| 17784016 | INFLUENZA ARRAYS AND USE THEREOF | Final Rejection | NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD. |
| 17835235 | FLAVIVIRUS ARRAYS AND USE THEREOF | Final Rejection | NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy